Literature DB >> 8334747

Reversibility of hypogonadotrophic hypogonadism associated with genetic haemochromatosis.

T Cundy1, J Butler, A Bomford, R Williams.   

Abstract

OBJECTIVE: Recent reports have suggested that hypogonadotrophic hypogonadism in men with genetic haemochromatosis can be reversed by aggressive venesection therapy. We have studied prospectively men with this complication of haemochromatosis in order to document the frequency and completeness of recovery from hypogonadism. PATIENTS AND
DESIGN: Six men with symptomatic hypogonadotrophic hypogonadism and genetic haemochromatosis were studied before beginning venesection therapy and again after depletion of body iron stores. MEASUREMENT: Symptoms of hypogonadism, serum gonadotrophins and serum total and free testosterone concentrations.
RESULTS: Five men aged 47-66 showed no symptomatic improvement and no change in serum gonadotrophin or testosterone concentrations. The symptoms of one man, aged 33, resolved completely after venesection and this was accompanied by increases in serum LH and FSH. Serum total and free testosterone concentrations increased fourfold, but remained subnormal.
CONCLUSION: Only one partial recovery from hypogonadotrophic hypogonadism was seen and this was in the youngest subject. In reviewing the other documented cases of reversal it would appear that the age at diagnosis is critical and there are no proven cases of reversal of hypogonadotrophic hypogonadism in men over the age of 40 at the start of venesection therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8334747     DOI: 10.1111/j.1365-2265.1993.tb02143.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

Review 1.  Iron and a Man's Reproductive Health: the Good, the Bad, and the Ugly.

Authors:  J Scott Gabrielsen; Dolores J Lamb; Larry I Lipshultz
Journal:  Curr Urol Rep       Date:  2018-06-01       Impact factor: 3.092

2.  Haemochromatosis as an endocrine cause of subfertility.

Authors:  M J Tweed; J M Roland
Journal:  BMJ       Date:  1998-03-21

3.  Hypopituitarism in primary haemochromatosis; recovery after iron depletion.

Authors:  R Gama; M J Smith; J Wright; V Marks
Journal:  Postgrad Med J       Date:  1995-05       Impact factor: 2.401

4.  Association between iron overload and osteoporosis in patients with hereditary hemochromatosis.

Authors:  L Valenti; M Varenna; A L Fracanzani; V Rossi; S Fargion; L Sinigaglia
Journal:  Osteoporos Int       Date:  2008-07-26       Impact factor: 4.507

Review 5.  Endocrine dysfunction in hereditary hemochromatosis.

Authors:  C Pelusi; D I Gasparini; N Bianchi; R Pasquali
Journal:  J Endocrinol Invest       Date:  2016-03-07       Impact factor: 4.256

Review 6.  All patients with 'idiopathic' hypopituitarism should be screened for hemochromatosis.

Authors:  Anthony S Lewis; C Hamish Courtney; A Brew Atkinson
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

7.  Hypogonadotropic hypogonadism in men with hereditary hemochromatosis.

Authors:  Rabih El Osta; Nicolas Grandpre; Nicolas Monnin; Jacques Hubert; Isabelle Koscinski
Journal:  Basic Clin Androl       Date:  2017-07-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.